Collaborative Registry of Patients With Thyroid Cancer and/or Thyroid Tumors (TCCR)

This study is currently recruiting participants. (see Contacts and Locations)
Verified January 2013 by University of Nebraska
Sponsor:
Information provided by (Responsible Party):
Whitney Goldner, MD, University of Nebraska
ClinicalTrials.gov Identifier:
NCT00693368
First received: June 6, 2008
Last updated: January 28, 2013
Last verified: January 2013
  Purpose

RATIONALE: This is a registry to gather information about patients with thyroid cancer or thyroid nodules which will facilitate the future study of thyroid nodules and thyroid cancer. There is also an associated biobank with this study for tissue, blood, DNA, and urine.

PURPOSE: To develop a Thyroid nodule and Thyroid cancer registry with associated biobank which will facilitate the future study of Thyroid nodules and cancer to help with detection, diagnosis and appropriate treatment of Thyroid cancer.


Condition
Neoplasms, Thyroid

Study Type: Observational
Official Title: Development and Implementation of The Thyroid Tumor and Cancer Collaborative Registry (TCCR)

Resource links provided by NLM:


Further study details as provided by University of Nebraska:

Primary Outcome Measures:
  • Development and implementation of a web-based Thyroid Tumor and Cancer Collaborative Registry at the University of Nebraska Medical Center (UNMC)/Nebraska Medical Center (NMC) [ Time Frame: ongoing ] [ Designated as safety issue: No ]
    This is a registry that will continue to accrue patients indefinitely

  • Procurement and banking of excess biological material (i.e., thyroid tissue, tumor tissue and/or metastatic thyroid cancer tissue and/or paraffin embedded tissue) for future analysis [ Time Frame: ongoing ] [ Designated as safety issue: No ]
    This is a registry and biobank and will continue to accrue indefinitely

  • Collection and banking of blood, DNA, and urine samples for future analysis that will be proposed in future IRB submissions [ Time Frame: ongoing ] [ Designated as safety issue: No ]
    This is a registry with biobank and accrual will continue indefinitely


Biospecimen Retention:   Samples With DNA

serum, plasma, DNA, urine, tissue


Estimated Enrollment: 2000
Study Start Date: February 2008
Estimated Study Completion Date: January 2025
Estimated Primary Completion Date: January 2025 (Final data collection date for primary outcome measure)
Groups/Cohorts
Thyroid nodule and Cancer
No Treatment

  Show Detailed Description

  Eligibility

Ages Eligible for Study:   19 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Adults with thyroid nodules or thyroid cancer

Criteria

Inclusion Criteria:

  • Meets either of the following criteria:

    • Diagnosis or history of thyroid cancer
    • Presence of one or more thyroid nodules

PATIENT CHARACTERISTICS:

  • Able to provide written informed consent

PRIOR CONCURRENT THERAPY:

  • Not specified
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00693368

Contacts
Contact: Michelle Ingram, BS 402-559-6277 michelle.ingram@unmc.edu
Contact: Kelly Treude, BS 402-559-7380 ktreude@unmc.edu

Locations
United States, Nebraska
Clinical Trials Patient Advocate Office Recruiting
Omaha, Nebraska, United States, 68198
Contact: Deb Meyer    402-559-6941      
Sponsors and Collaborators
University of Nebraska
Investigators
Principal Investigator: Whitney S. Goldner, MD UNMC Internal Medicine (DEM), and Eppley Cancer Center at the University of Nebraska Medical Center
  More Information

Additional Information:
Publications:
Responsible Party: Whitney Goldner, MD, Associate Professor, Internal Medicine, DEM, University of Nebraska
ClinicalTrials.gov Identifier: NCT00693368     History of Changes
Other Study ID Numbers: 463-07, MXH:99-925-1355
Study First Received: June 6, 2008
Last Updated: January 28, 2013
Health Authority: United States: Institutional Review Board

Keywords provided by University of Nebraska:
thyroid cancer
thyroid nodules

Additional relevant MeSH terms:
Thyroid Diseases
Thyroid Neoplasms
Endocrine System Diseases
Endocrine Gland Neoplasms
Neoplasms by Site
Neoplasms
Head and Neck Neoplasms

ClinicalTrials.gov processed this record on October 19, 2014